Publications in 2023
Perez-Nadales E, Fernandez-Ruiz M, Natera AM, Gutierrez-Gutierrez B, Mularoni A, Russelli G, Pierrotti LC, Freire MP, Falcone M, Tiseo G, Tumbarello M, Raffaelli F, Abdala E, Bodro M, Gervasi E, Farinas MC, Seminari EM, Caston JJ, Marin-Sanz JA, Galvez-Soto V, Rana MM, Loeches B, Martin-Davila P, Pascual A, Rodriguez-Bano J, Aguado JM, Martinez-Martinez L, Torre-Cisneros J, REIPI INCREMENT-SOT Study Grp. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae. AMERICAN JOURNAL OF TRANSPLANTATION. 2023. 1022-1034. DOI: 10.1016/j.ajt.2023.03.011. IF: 8,8 Q1 D1
Sanchez-Leon I, Garcia-Martinez T, Diene SM, Perez-Nadales E, Martinez-Martinez L, Rolain JM. Heteroresistance to Colistin in Clinical Isolates of Klebsiella pneumoniae Producing OXA-48. ANTIBIOTICS-BASEL. 2023. DOI: 10.3390/antibiotics12071111. IF: 4,8 Q2 D4
Fernandez-Moreno R, Valle-Arroyo J, Paez-Vega A, Salinas A, Cano A, Perez AB, Torre-Cisneros J, Cantisan S. Memory SARS-CoV-2 T-cell response in convalescent COVID-19 patients with undetectable specific IgG antibodies: a comparative study. FRONTIERS IN IMMUNOLOGY. 2023. DOI: 10.3389/fimmu.2023.1142918. IF: 7,3 Q1 D3
Blanco-Martin T, Guzman-Puche J, Riazzo C, Gasca-Santiyan M, Hernandez-Garcia M, Canton R, Torre-Cisneros J, Herrera C, Martinez-Martinez L. Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated bla(IMI-6) Gene. MICROBIOLOGY SPECTRUM. 2023. DOI: 10.1128/spectrum.04620-22. IF: 3,7 Q2 D5
de la Fuente C, Rodriguez M, Merino N, Carmona P, Machuca I, Cordoba-Fernandez M, Guzman-Puche J, Dominguez A, Lopez-Vinau T, Garcia L, Vaquero JM, Robles JC, Martinez-Martinez L, Torre-Cisneros J. Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023. DOI: 10.1016/j.ijantimicag.2023.106818. IF: 10,8 Q1 D2
Trigo-Rodriguez M, Carcel S, Navas A, Espindola-Gomez R, Garrido-Gracia JC, Moreno MAE, Leon-Lopez R, Perez-Crespo PMM, Alonso EA, Vinuesa D, Romero-Palacios A, Perez-Camacho I, Gutierrez-Gutierrez B, Martinez-Marcos FJ, Fernandez-Roldan C, Leon E, Cano AA, Corzo-Delgado JE, Perez-Nadales E, Riazzo C, de la Fuente C, Jurado A, Torre-Cisneros J, Merchante N. Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial. OPEN FORUM INFECTIOUS DISEASES. 2023. DOI: 10.1093/ofid/ofad133. IF: 4,2 Q2 D5
Castillo-Fernandez N, Perez-Crespo PMM, Salamanca-Rivera E, Herrera-Hidalgo L, de Alarcon A, Navarro-Amuedo MD, Ciordia TM, Perez-Rodriguez MT, Sevilla-Blanco J, Jover-Saenz A, Fernandez-Suarez J, Arminanzas-Castillo C, Reguera-Iglesias JM, Kindelan CN, Boix-Palop L, Jimenez EL, Galan-Sanchez F, Jimenez AD, Bahamonde-Carrasco A, Garcia DV, Amat AS, Pedragosa JC, Molina IMR, Camacho IP, de Lucas EM, Gutierrez-Gutierrez B, Bano JR, Cortes LEL. Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort. ANTIBIOTICS-BASEL. 2023. DOI: 10.3390/antibiotics12010129. IF: 4,8 Q2 D4
Fernandes TR, Mariscal M, Serrano A, Segorbe D, Fernandez-Acero T, Martin H, Turra D, Di Pietro A. Cytosolic pH Controls Fungal MAPK Signaling and Pathogenicity. MBIO. 2023. DOI: 10.1128/mbio.00285-23. IF: 6,4 Q1 D2
Sojo-Dorado J, Lopez-Hernandez I, Hernandez-Torres A, Retamar-Gentil P, de Lucas EM, Escola-Verge L, Bereciartua E, Garcia-Vazquez E, Pintado V, Boix-Palop L, Natera-Kindelan C, Sorli L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martinez-Alvarez RM, Duenas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jimenez V, Docobo-Perez F, Pascual A, Rodriguez-Bano J. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023. 1658-1666. DOI: 10.1093/jac/dkad147. IF: 5,2 Q2 D3
Branas F, Torralba M, Antela A, Vergas J, Ramirez M, Ryan P, Dronda F, Galindo MJ, Machuca I, Bustinduy MJ, Cabello A, Montes ML, Sanchez-Conde M. Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV. BMC GERIATRICS. 2023. DOI: 10.1186/s12877-022-03719-8. IF: 4,1 Q1 D3
Fernandez-Ruiz M, Bodro M, Martin IG, Rodriguez-Alvarez R, Ruiz-Ruigomez M, Sabe N, Lopez-Vinau T, Valerio M, Illaro A, Fortun J, Salto-Alejandre S, Cordero E, Farinas MD, Munoz P, Vidal E, Carratala J, Goikoetxea J, Ramos-Martinez A, Moreno A, Aguado JM. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice. TRANSPLANTATION. 2023. 762-773. DOI: 10.1097/TP.0000000000004312. IF: 6,2 Q1 D2
Atamna A, Margalit I, Ayada G, Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, de Cueto M, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstei Y, Yahav D. Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. INFECTION. 2023. 1003-1012. DOI: 10.1007/s15010-022-01973-x. IF: 7,5 Q1 D2
Troeman DPR, Hazard D, Timbermont L, Malhotra-Kumar S, van Werkhoven CH, Wolkewitz M, Ruzin A, Goossens H, Bonten MJM, Harbarth S, Sifakis F, Kluytmans JAJW, Vlaeminck J, Vilken T, Xavier BB, Lammens C, van Esschoten M, Paling FP, Recanatini C, Coenjaerts F, Sellman B, Tkaczyk C, Weber S, Ekkelenkamp MB, van der Laan L, Vierhout BP, Couve-Deacon E, David M, Chadwick D, Llewelyn M, Ustianowski A, Bateman A, Mawer D, Carevic B, Konstantinovic S, Djordjevic Z, del Toro-Lopez MD, Gallego JPH, Escudero D, Rojo MP, Torre-Cisneros J, Castelli F, Nardi G, Barbadoro P, Altmets M, Mitt P, Todor A, Bubenek-Turconi SI, Corneci D, Sandesc D, Gheorghita V, Brat R, Hanke I, Neumann J, Tomas T, Laffut W, van den Abeele AM. Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization. JAMA NETWORK OPEN. 2023. DOI: 10.1001/jamanetworkopen.2023.39793. IF: 13,8 Q1 D1
Perez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J, Sojo-Dorado J, Schotsman J, Canton R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Reguera JM, de Santis LV, Torre-Cisneros J, Cano A, Roilides E, Radulovic L, Kirakli C, Shaw E, Falagas ME, Pintado V, Goossens H, Bonten MJ, Gutierrez-Gutierrez B, Rodriguez-Bano J. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control- control study (EURECA). ECLINICALMEDICINE. 2023. DOI: 10.1016/j.eclinm.2023.101871. IF: 15,1 Q1 D1
Publications in 2022
Cano A, Gutierrez-Gutierrez B, Machuca I, Torre-Gimenez J, Frutos-Adame A, Garcia-Gutierrez M, Gallo-Marin M, Gracia-Ahufinger I, Artacho MJ, Natera AM, Perez-Nadales E, Caston JJ, Mameli S, Gomez-Delgado F, de la Fuente C, Salcedo I, Rodriguez-Bano J, Martinez-Martinez L, Torre-Cisneros J. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2022. DOI: 10.1016/j.jgar.2021.10.024
Cano A, Gutierrez-Gutierrez B, Machuca I, Torre-Gimenez J, Gracia-Ahufinger I, Natera AM, Perez-Nadales E, Caston JJ, Rodriguez-Bano J, Martinez-Martinez L, Torre-Cisneros J. MICROBIOLOGY SPECTRUM. 2022. DOI: 10.1128/spectrum.01970-21
Machuca I, Guzman-Puche J, Perez-Nadales E, Gracia-Ahufinger I, Mendez A, Cano A, Caston JJ, Dominguez A, Torre-Cisneros J, Martinez-Martinez L. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2022. DOI: 10.1016/j.jgar.2022.07.017
Vidal-Cortes P, Martin-Loeches I, Rodriguez A, Bou G, Canton R, Diaz E, De la Fuente C, Torre-Cisneros J, Nuvials FX, Salavert M, Aguilar G, Nieto M, Ramirez P, Borges M, Soriano C, Ferrer R, Maseda E, Zaragoza R. ANTIBIOTICS-BASEL. 2022. DOI: 10.3390/antibiotics11091160
Kotton CN, Torre-Cisneros J. TRANSPLANT INFECTIOUS DISEASE. 2022. DOI: 10.1111/tid.13977
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Grier S, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, de Cueto M, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. INFECTIOUS DISEASES AND THERAPY. 2022. DOI: 10.1007/s40121-022-00657-1
Merchante N, Carcel S, Garrido-Gracia JC, Trigo-Rodriguez M, Moreno MAE, Leon-Lopez R, Espindola-Gomez R, Alonso EA, Garcia DV, Romero-Palacios A, Perez-Camacho I, Gutierrez-Gutierrez B, Martinez-Marcos FJ, Fernandez-Roldan C, Perez-Crespo PMM, Cano AA, Leon E, Corzo JE, de la Fuente C, Torre-Cisneros J. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2022. DOI: 10.1128/aac.02107-21
Sojo-Dorado J, Lopez-Hernandez I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernandez-Torres A, de Lucas EM, Escola-Verge L, Bereciartua E, Garcia-Vazquez E, Pintado V, Boix-Palop L, Natera-Kindelan C, Sorli L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martinez-Alvarez RM, Duenas CJ, Calvo-Montes J, Silva JT, Cardenes MA, Lecuona M, Pomar V, de Santis LV, Yague-Guirao G, Lobo-Acosta MA, Merino-Bohorquez V, Pascual A, Rodriguez-Bano J. JAMA NETWORK OPEN. 2022. DOI: 10.1001/jamanetworkopen.2021.37277
Perez-Nadales E, Fernandez-Ruiz M, Gutierrez-Gutierrez B, Pascual A, Rodriguez-Bano J, Martinez-Martinez L, Aguado JM, Torre-Cisneros J. TRANSPLANT INFECTIOUS DISEASE. 2022. DOI: 10.1111/tid.13881
Jimenez-Rodriguez RM, Martin-Gutierrez G, Jimenez-Jorge S, Rosso-Fernandez CM, Tallon-Aguilar L, Roca-Oporto C, Padillo J, Luckey A, Cano A, Lopez-Ruiz J, Gomez-Zorrilla S, Bonnin-Pascual J, Boix-Palop L, Montejo JM, Torre-Cisneros J, Cisneros JM. BMJ OPEN. 2022. DOI: 10.1136/bmjopen-2021-051187
Escudero-Sanchez R, Garcia AM, Fernandez SG, Alijo AV, Pitarch MT, De Lucas EM, Rojas AG, Martinez AR, Lleti MS, Giner L, Ruigomez MR, Basas LG, Fradejas JF, Sampedrio MO, Yuste AC, Pollan BD, Hernandez MJR, Segarra OM, Bejar CS, Castillo CA, Gutierrez B, Rodriguez-Pardo D, Cisneros JD, Medrano FL, Reinoso JC. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022. DOI: 10.1093/jac/dkac106
Bravo MS, Plault N, Sanchez-Palomino S, Rodriguez C, Gabriel MN, Mosquera MM, Avilas FF, Suarez-Lledo M, Rovira M, Bodro M, Moreno A, Linares L, Cofan F, Berengua C, Esteva C, Cordero E, Martin-Davila P, Aranzamendi M, Jimenez ABP, Vidal E, Sabe NF, Len O, Hantz S, Alain S, Marcos MA. JOURNAL OF INFECTIOUS DISEASES. 2022. DOI: 10.1093/infdis/jiac349
Paez-Vega A, Gutierrez-Gutierrez B, Aguera ML, Facundo C, Redondo-Pachon D, Suner M, Lopez-Oliva MO, Yuste JR, Montejo M, Galeano-Alvarez C, Ruiz-San Millan JC, Los-Arcos I, Hernandez D, Fernandez-Ruiz M, Munoz P, Valle-Arroyo J, Cano A, Rodriguez-Benot A, Crespo M, Rodelo-Haad C, Lobo-Acosta MA, Garrido-Gracia JC, Vidal E, Guirado L, Cantisan S, Torre-Cisneros J. CLINICAL INFECTIOUS DISEASES. 2022. DOI: 10.1093/cid/ciab574
Caston JJ, Cano A, Perez-Camacho I, Aguado JM, Carratala J, Ramasco F, Soriano A, Pintado V, Castelo-Corral L, Sousa A, Farinas MC, Munoz P, De Medrano VAL, Sanz-Pelaez O, Los-Arcos I, Gracia-Ahufinger I, Perez-Nadales E, Vidal E, Doblas A, Natera C, Martinez-Martinez L, Torre-Cisneros J. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022. DOI: 10.1093/jac/dkac049
Papalois V, Kotton CN, Budde K, Torre-Cisneros J, Croce D, Halleck F, Roze S, Grossi P. TRANSPLANT INTERNATIONAL. 2022. DOI: 10.3389/ti.2022.10302
Delgado-Sanchez S, Serrano-Ortiz A, Ruiz-Montero R, Lorusso N, Rumbao-Aguirre JM, Salcedo-Leal I. JOURNAL OF HEALTHCARE QUALITY RESEARCH. 2022. DOI: 10.1016/j.jhqr.2021.12.006
Guzman-Puche J, Perez-Nadales E, Perez-Vazquez M, Causse M, Gracia-Ahufinger I, Mendez-Natera A, Allalou-Ruiz Y, Elias C, Oteo-Iglesias J, Torre-Cisneros J, Martinez-Martinez L. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2022. DOI: 10.1016/j.ijantimicag.2022.106524
Bodro M, Cervera C, Linares L, Suarez B, Llopis J, Sanclemente G, Casado-Llombart S, Fernandez-Ruiz M, Farinas MC, Cantisan S, Montejo M, Cordero E, Oriol I, Marcos MA, Lozano F, Moreno A, Invest (GERSITRA IC SEIMC REIPI invest). FRONTIERS IN IMMUNOLOGY. 2022. DOI: 10.3389/fimmu.2022.897912
Perez-Nadales E, Natera AM, Recio-Rufian M, Guzman-Puche J, Cano A, Frutos-Adame A, Caston JJ, Elias-Lopez C, Romero-Saldana M, Lopez-Cerero L, Martinez-Martinez L. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2022. DOI: 10.1016/j.jgar.2022.04.010
Perez-Crespo PMM, Rojas A, Lanz-Garcia JF, Retamar-Gentil P, Reguera-Iglesias JM, Lima-Rodriguez O, Jimenez AD, Suarez JF, Jover-Saenz A, Aguirre JG, Jimenez EL, Canton-Bulnes ML, Lafont PO, Castillo CA, Blanco JS, Pedragosa JC, Boix-Palop L, Carral BB, Bahamonde-Carrasco A, Ciordia TM, Kindelan CN, Molina IMR, Rodriguez CH, Camacho IP, Garcia DV, Galan-Sanchez F, Amat AS, de Lucas EM, Sanchez-Porto A, Garcia MG, Lopez-Hernandez I, Rodriguez-Bano J, Lopez-Cortes LE. ANTIBIOTICS-BASEL. 2022. DOI: 10.3390/antibiotics11060707
Perez-Nadales E, Cano A, Recio M, Artacho MJ, Guzman-Puche J, Doblas A, Vidal E, Natera C, Martinez-Martinez L, Torre-Cisneros J, Caston JJ. BMJ OPEN. 2022. DOI: 10.1136/bmjopen-2021-058124
Molina J, Montero-Mateos E, Praena-Segovia J, Leon-Jimenez E, Natera C, Lopez-Cortes LE, Valiente L, Rosso-Fernandez CM, Herrero M, Aller-Garcia AI, Cano A, Gutierrez-Gutierrez B, Marquez-Gomez I, Alvarez-Marin R, Infante C, Roca C, Valiente-Mendez A, Pachon J, Reguera JM, Corzo-Delgado JE, Torre-Cisneros J, Rodriguez-Bano J, Cisneros JM, Team ST. CLINICAL MICROBIOLOGY AND INFECTION. 2022. DOI: 10.1016/j.cmi.2021.09.001
Publications in 2021
Pierrotti LC, Pérez-Nadales E, Fernández-Ruiz M, Gutierrez-Gutierrez B, Tan BH, Carratala J, Oriol I, Paul M, Cohen-Sinai N, López-Medrano F, San-Juan R, Montejo M, Freire MP, Cordero E, David MD, Merino E, Steinke SM, Grossi PA, Cano A, Seminari EM, Valerio M, Gunseren F, Rana M, Mularoni A, Martin-Davila P, van Delden C, Demirkaya MH, Tufan ZK, Loeches B, Iyer RN, Soldani F, Eriksson BM, Pilmis B, Rizzi M, Coussement J, Clemente WT, Roilides E, Pascual A, Martinez-Martinez L, Rodriguez-Bano J, Torre-Cisneros J, Aguado JM. Efficacy of beta-lactam/beta-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project). TRANSPLANT INFECTIOUS DISEASE. 202 23(3):-. DOI: 10.1111/tid.13520.
IF: 2,228 Q3 D
Fernández-Moreno R, Torre-Cisneros J, Cantisan S. Human cytomegalovirus (HCMV)-encoded microRNAs: potential biomarkers and clinical applications. RNA BIOLOGY. 2021. 18(12):2194-220 DOI: 10.1080/15476286.2021.1930757.
IF: 4,652 Q2 D4
Lopez-Vinau T, Penalva G, Garcia-Martinez L, Caston JJ, Munoz-Rosa M, Cano A, Recio M, Cisneros JM, Perez-Nadales E, Aguirre JR, Garcia-Martinez E, Salcedo I, del Prado JR, de la Fuente C, Martinez-Martinez L, Gracia-Ahufinger I, Torre-Cisneros J. Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis. ANTIBIOTICS-BASEL. 2021. 10(5):. DOI: 10.3390/antibiotics10050586.
IF: 4,639 Q2 D3
Pérez-Nadales E, Alastruey-Izquierdo A, Linares-Sicilia MJ, Soto-Debran JC, Abdala E, Garcia-Rodriguez J, Montejo M, Munoz P, Lleti MS, Rezusta A, de Pipaon MRP, Yanez L, Merino E, Campos-Herrero MI, Costa-Mateo JM, Fortun J, Garcia-Lozano T, Garcia-Vidal C, Fernandez-Ruiz M, Sanchez-Reus F, Castro-Mendez C, Guerrero-Lozano I, Soler-Palacin P, Aguado JM, Martinez-Martinez L, Torre-Cisneros J, Nucci M. Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015. EMERGING INFECTIOUS DISEASES. 2021. 27(1):26-35. DOI: 10.3201/eid2701.190782.
IF: 6,883 Q1 D1
Paez-Vega A, Cantisan S, Aguera ML, Suner M, Facundo C, Yuste JR, Fernandez-Ruiz M, Montejo M, Redondo-Pachon D, Lopez-Oliva MO, Fernandez-Rodriguez A, Farinas MC, Hernandez D, Len O, Munoz P, Valle-Arroyo J, Rodelo-Haad C, Cordero E, Torre-Cisneros J. Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation. JOURNAL OF INFECTIOUS DISEASES. 2021. 223(7):1205-1213. DOI: 10.1093/infdis/jiaa503.
IF: 5,226 Q1 D2
Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 202 326(6):499-518. DOI: 10.1001/jama.20211330.
IF: 56,272 Q1 D1
Alvarez-Marin R, Lepe JA, Gasch-Blasi O, Rodriguez-Martinez JM, Calvo-Montes J, Lara-Contreras R, Martin-Gandul C, Tubau-Quintano F, Cano-Garcia ME, Rodriguez-Lopez F, Rodriguez-Bano J, Pujol-Rojo M, Torre-Cisneros J, Martinez-Martinez L, Pascual-Hernandez A, Jimenez-Mejias ME. Clinical characteristics and outcome of bacteraemia caused by Enterobacter cloacae and Klebsiella aerogenes: more similarities than differences. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2021. 25():351-358. DOI: 10.1016/j.jgar.2021.04.008BY-.
IF: 4,035 Q2 D4
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, MacGowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Mauer S, Rodriguez-Bano J, Morales I, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez LM, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 202 76(8):2172-218 DOI: 10.1093/jac/dkab134.
IF: 5,79 Q1 D2
Nucci M, Jenks J, Thompson GR, Hoenigl M, dos Santos MC, Forghieri F, Rico JC, Bonuomo V, Lopez-Soria L, Lass-Florl C, Candoni A, Garcia-Vidal C, Cattaneo C, Buil J, Rabagliati R, Roiz MP, Gudiol C, Fracchiolla N, Campos-Herrero MI, Delia M, Farina F, Fortun J, Nadali G, Sastre E, Colombo AL, Nadales EP, Alastruey-Izquierdo A, Pagano L. Do high MICs predict the outcome in invasive fusariosis?. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021. 76(4):1063-1069. DOI: 10.1093/jac/dkaa516.
IF: 5,79 Q1 D2
Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Lodise TP, Naas T, Niki Y, Paterson DL, Portsmouth S, Torre-Cisneros J, Toyoizumi K, Wunderink RG, Nagata TD. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. LANCET INFECTIOUS DISEASES. 2021. 21(2):226-240. DOI: 10.1016/S1473-3099(20)30796-9.
IF: 25,071 Q1 D1
Ruiz-Ruigomez M, Fernandez-Ruiz M, Silva JT, Vidal E, Origuen J, Calvo-Cano A, Luna-Huerta E, Merino E, Hernandez D, Jironda-Gallegos C, Escudero-Sanchez R, Gioia F, Moreno A, Roca C, Cordero E, Janeiro D, Sanchez-Sobrino B, Montero MM, Redondo D, Candel FJ, Perez-Flores I, Arminanzas C, Gonzalez-Rico C, Farinas MC, Rodrigo E, Loeches B, Lopez-Oliva MO, Montejo M, Lauzurica R, Horcajada JP, Pascual J, Andres A, Aguado JM, Lopez-Medrano F. Efficacy and Safety of Oral Fosfomycin for Asymptomatic Bacteriuria in Kidney Transplant Recipients: Results from a Spanish Multicenter Cohort. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021. 65(5):-. DOI: 10.1128/AAC.02267-20.
IF: 5,191 Q1 D3
Pérez-Crespo PMM, López-Cortes LE, Retamar-Gentil P, Garcia JFL, Garcia D, Leon E, Calvo JMS, Galan-Sanchez F, Kindelan CN, Jiménez AD, Sanchez-Porto A, Rodriguez CH, Carral BB, Molina IMR, Iglesias JMR, Camacho IP, Garcia MG, Lopez-Hernandez I, Rodriguez-Bano J. Epidemiologic changes in bloodstream infections in Andalucia (Spain) during the last decade. CLINICAL MICROBIOLOGY AND INFECTION. 2021. 27(2):283.e9-283.e16. DOI: 10.1016/j.cmi.2020.0015.
IF: 8,067 Q1 D1
van Werkhoven CH, Ducher A, Berkell M, Mysara M, Lammens C, Torre-Cisneros J, Rodriguez-Bano J, Herghea D, Cornely OA, Biehl LM, Bernard L, Dominguez-Luzon MA, Maraki S, Barraud O, Nica M, Jazmati N, Sablier-Gallis F, de Gunzburg J, Mentre F, Malhotra-Kumar S, Bonten MJM, Vehreschild MJGT. Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics. NATURE COMMUNICATIONS. 2021. 12(1):-. DOI: 10.1038/s41467-021-22269-y.
IF: 14,919 Q1 D1
Gioia F, Filigheddu E, Corbella L, Fernandez-Ruiz M, Lopez-Medrano F, Perez-Ayala A, Aguado JM, Farinas MC, Arnaiz F, Calvo J, Cifrian JM, Gonzalez-Rico C, Vidal E, Torre-Cisneros J, Ras MM, Perez S, Sabe N, Lopez-Soria LM, Rodriguez-Alvarez RJ, Montejo JM, Valerio M, Machado M, Munoz P, Linares L, Bodro M, Moreno A, Fernandez-Cruz A, Canton R, Moreno S, Martin-Davila P, Fortun J. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study). MYCOSES. 2021. 64(11):1334-1345. DOI: 10.1111/myc.13298.
IF: 4,377 Q1 D3
Escudero-Sanchez R, Ruiz-Ruigomez M, Fernandez-Fradejas J, Fernandez SG, Samperio MO, Yuste AC, Alijo AV, Diaz-Pollan B, Hernandez MJR, De Lucas EM, Segarra OM, Bejar CS, Castillo CA, Gutierrez-Gutierrez B, Rodriguez-Pardo D, Ramos-Martinez A, Torre-Cisneros J, López-Medrano F, Reinoso JC. Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection. JOURNAL OF CLINICAL MEDICINE. 2021. 10(1):-. DOI: 10.3390/jcm10010002.
IF: 4,241 Q1 D3 ES DEL 2020 SEGÚN WOS SE PUBLICÓ DEFINITIVAMENTE EN 2021
Pérez-Crespo PMM, Lanz-Garcia JF, Bravo-Ferrer J, Canton-Bulnes ML, Dominguez AS, Aguirre JG, Reguera-Iglesias JM, Jimenez EL, Castillo CA, Vallejo MAM, Ciordia TM, Suarez JF, Boix-Palop L, Pedragosa JC, Saenz AJ, Blanco JS, Galan-Sanchez F, Kindelan CN, Jimenez AD, Bahamonde-Carrasco A, Amat AS, Garcia DV, Rodriguez CH, Molina IMR, Camacho IP, Sánchez-Porto A, García MG, Carral BB, de Lucas EM, Lopez-Hernandez I, Rodriguez-Bano J, Lopez-Cortes LE. Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study). INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2021. 58(1):-. DOI: 10.1016/j.ijantimicag.2021.10635
IF: 5,283 Q1 D2
Salto-Alejandre S, Jiménez-Jorge S, Sabe N, Ramos-Martinez A, Linares L, Valerio M, Martin-Dávila P, Fernández-Ruiz M, Fariñas MC, Blanes-Julia M, Vidal E, Palacios-Baena ZR, Hernandez-Gallego R, Carratala J, Calderon-Parra J, Angeles Marcos M, Munoz P, Fortun-Abete J, Aguado JM, Arnaiz-Revillas F, Blanes-Hernandez R, de la Torre-Cisneros J, Lopez-Cortes LE, de Vinuesa-Calvo EG, Rosso CM, Pachon J, Sanchez-Cespedes J, Cordero E. Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study. PLOS ONE. 2021. 16(4):-. DOI: 10.1371/journal.pone.0250796.
IF: 3,24 Q2 D4
de Bruyn G, Gordon DL, Steiner T, Tambyah P, Cosgrove C, Martens M, Bassily E, Chan ES, Patel D, Chen J, Torre-Cisneros J, Francesconi CFD, Gesser R, Jeanfreau R, Launay O, Laot T, Morfin-Otero R, Oviedo-Orta E, Park YS, Piazza FM, Rehm C, Rivas E, Self S, Gurunathan S. Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial. LANCET INFECTIOUS DISEASES. 2021. 21(2):252-262. DOI: 10.1016/S1473-3099(20)30331-5.
IF: 25,071 Q1 D1
Publications in 2020
Alvarez-Marin R, Navarro-Amuedo D, Gasch-Blasi O, Rodriguez-Martinez JM, Calvo-Montes J, Lara-Contreras R, Lepe-Jimenez JA, Tubau-Quintano F, Cano-Garcia ME, Rodriguez-Lopez F, Rodriguez-Bano J, Pujol-Rojo M, Torre-Cisneros J, Martinez-Martinez L, Pascual. A prospective, multicenter case control study of risk factors for acquisition and mortality in Enterobacter species bacteremia. JOURNAL OF INFECTION. 2020. 80 (2):174-181 DOI: 10.1016/j.jinf.2019.09.017
IF: 4,842 Q: 1
Ramos-Vivas J, Chapartegui-Gonzalez I, Fernandez-Martinez M, Gonzalez-Rico C, Barrett J, Fortun J, Escudero R, Marco F, Linares L, Nieto J, Aranzamendi M, Munoz P, Valerio M, Aguado JM, Chaves F, Gracia-Ahufinger I, Paez-Vega A, Martinez-Martinez L, Farinas MC. Adherence to Human Colon Cells by Multidrug ResistantEnterobacteralesStrains Isolated From Solid Organ Transplant Recipients With a Focus onCitrobacter freundii. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2020. 10 ():- DOI: 10.3389/fcimb.2020.00447
IF: 4,123 Q: 2
Rua-Figueroa I, Lopez-Longo FJ, Del Campo V, Galindo-Izquierdo M, Uriarte E, Torre-Cisneros J, Vela P, Tomero E, Narvaez J, Olive A, Freire M, Salgado E, Andreu JL, Martinez-Taboada V, Calvo-Alen J, Hernandez-Cruz B, Raya E, Quevedo V, Perez LE, Fernandez. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes. JOURNAL OF RHEUMATOLOGY. 2020. 47 (2):234-240 DOI: 10.3899/jrheum.180882
IF: 3,35 Q: 2
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, Macgowan A, Grier S, Gibbs J, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl . Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study. CLINICAL INFECTIOUS DISEASES. 2020. 70 (11):2270-2280 DOI: 10.1093/cid/ciz668
IF: 8,313 Q: 1 D: 1
Castan JJ, Gallo M, Garcia M, Cano A, Escribano A, Machuca I, Gracia-Aufinger I, Guzman-Puche J, Perez-Nadales E, Recio M, Munoz M, Martinez-Martinez L, Torre-Cisneros J. Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020. 56 (3):- DOI: 10.1016/j.ijantimicag.2020.106075
IF: 4,621 Q: 1
Cordero E, Bulnes-Ramos A, Aguilar-Guisado M, Escribano FG, Olivas I, Torre-Cisneros J, Gavalda J, Aydillo T, Moreno A, Montejo M, Farinas MC, Carratala J, Munoz P, Blanes M, Fortun J, Suarez-Benjumea A, Lopez-Medrano F, Roca C, Lara R, Perez-Romero P. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients. FRONTIERS IN IMMUNOLOGY. 2020. 11 ():- DOI: 10.3389/fimmu.2020.01917
IF: 5,085 Q: 1
Lopez RL, Fernandez SC, Perez LL, Palacios AR, Fernandez-Roldan MC, Alonso EA, Camacho IP, Rodriguez-Bano J, Merchante N, Olalla J, Esteban-Moreno MA, Santos M, Luque-Pineda A, Torre-Cisneros J. Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial. BMJ OPEN. 2020. 10 (11):- DOI: 10.1136/bmjopen-2020-039951
IF: 2,496 Q: 2
Len O, Los-Arcos I, Aguado JM, Blanes M, Bodro M, Carratala J, Cordero E, Farinas MC, Fernandez-Ruiz M, Fortun J, Gavalda J, Lopez-Medrano F, Lopez-Velez R, Lumbreras C, Mahillo B, Marcos MA, Martin-Davila P, Montejo JM, Moreno A, Munoz P, Norman F, Perez-Saenz JL, Pumarola T, Sabe N, San-Juan R, Vidal E, Dominguez-Gil B. Executive summary of the Consensus Document of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2020. 38 (8):379-389 DOI: 10.1016/j.eimc.2019.10.016
IF: 1,654 Q: 4
Bleriot I, Trastoy R, Blasco L, Fernandez-Cuenca F, Ambroa A, Fernandez-Garcia L, Perez-Nadales E, Torre-Cisneros J, Oteo-Iglesias J, Navarro F, Miro E, Pascual A, Bou G, Martinez-Martinez L, Tomas M. Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae. MICROBIAL GENOMICS. 2020. 6 (5):- DOI: 10.1099/mgen.0.000369
IF: 4,632 Q: 1 D: 1
Gamal D, Egea P, Elias C, Fernandez-Martinez M, Causse M, Perez-Nadales E, Salem D, Fam N, Diab M, Abu Aitta A, El-Defrawy I, Martinez-Martinez L. High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary-care centre in Egypt. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020. 56 (6):- DOI: 10.1016/j.ijantimicag.2020.106164
IF: 4,621 Q: 1
Rivera-Espinar F, Machuca I, Tejero R, Rodriguez J, Mula A, Marfil E, Cano A, Gutierrez-Gutierrez B, Rodriguez M, Pozo JC, De la Fuente C, Rodriguez-Bano J, Martinez-Martinez L, Leon R, Torre-Cisneros J. Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020. 64 (6):- DOI: 10.1128/AAC.02164-19
IF: 4,904 Q: 1
Blasco L, Ambroa A, Trastoy R, Bleriot I, Moscoso M, Fernandez-Garcia L, Perez-Nadales E, Fernandez-Cuenca F, Torre-Cisneros J, Oteo-Iglesias J, Oliver A, Canton R, Kidd T, Navarro F, Miro E, Pascual A, Bou G, Martinez-Martinez L, Tomas M. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens. SCIENTIFIC REPORTS. 2020. 10 (1):- DOI: 10.1038/s41598-020-64145-7
IF: 3,998 Q: 1
Delgado FJT, Cabrero JB, Gonzalez JM, Verdu EV, Lopez-Cillero P. Isolated pericardial echinococcosis as a manifestation of hepatic hydatid disease. LANCET INFECTIOUS DISEASES. 2020. 20 (8):992-992
IF: 24,446 Q: 1 D: 1
Valle-Arroyo J, Aguado R, Paez-Vega A, Perez AB, Gonzalez R, Fornes G, Torre-Cisneros J, Cantisan S. Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact. SCIENTIFIC REPORTS. 2020. 10 (1):- DOI: 10.1038/s41598-020-64133-x
IF: 3,998 Q: 1
Lopez-Medrano F, Silva JT, Fernandez-Ruiz M, Vidal E, Origuen J, Calvo-Cano A, Luna-Huerta E, Merino E, Hernandez D, Jironda-Gallegos C, Escudero R, Gioia F, Moreno A, Roca C, Cordero E, Janeiro D, Sanchez-Sobrino B, Montero MM, Redondo D, Candel FJ, Pere. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients-Results of a Spanish multicenter cohort. AMERICAN JOURNAL OF TRANSPLANTATION. 2020. 20 (2):451-462 DOI: 10.1111/ajt.15614
IF: 7,338 Q: 1 D: 1
Cornely OA, Cisneros JM, Torre-Cisneros J, Rodriguez-Hernandez MJ, Tallon-Aguilar L, Calbo E, Horcajada JP, Queckenberg C, Zettelmeyer U, Arenz D, Rosso-Fernandez CM, Jimenez-Jorge S, Turner G, Raber S, O'Brien S, Luckey A. Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2020. 75 (3):618-627 DOI: 10.1093/jac/dkz497
IF: 5,439 Q: 1 D: 1
Perez-Nadales E, Gutierrez-Gutierrez B, Natera AM, Abdala E, Magalhaes MR, Mularoni A, Monaco F, Pierrotti LC, Freire MP, Iyer RN, Steinke SM, Calvi EG, Tumbarello M, Falcone M, Fernandez-Ruiz M, Costa-Mateo JM, Rana MM, Strabelli TMV, Paul M, Farinas MC,. Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia. AMERICAN JOURNAL OF TRANSPLANTATION. 2020. 20 (6):1629-1641 DOI: 10.1111/ajt.15769
IF: 7,338 Q: 1 D: 1
Eichau S, Ruiz RL, Osorio JJC, Ramirez E, Dominguez-Mayoral A, Izquierdo G. Primary cytomegalovirus infection in a patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab. NEUROLOGIA. 2020. 35 (6):440-443 DOI: 10.1016/j.nrl.2018.03.015
IF: 2,283 Q: 3
Palacios-Baena ZR, de Santis LV, Maldonado N, Rosso-Fernandez CM, Borreguero I, Herrero-Rodriguez C, Lopez-Cardenas S, Martinez-Marcos FJ, Martin-Asbas A, Jimenez-Aguilar P, Caston JJ, Anguita-Santos F, Ojeda-Burgos G, Aznarte-Padial MP, Praena-Segovia J,. Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project. BMJ OPEN. 2020. 10 (7):- DOI: 10.1136/bmjopen-2019-035460
IF: 2,496 Q: 2
Gutierrez-Gutierrez B, Perez-Nadales E, Rodriguez-Bano J, Torre-Cisneros J. Reply to ""CMV merits further evolutionary and biological view"". AMERICAN JOURNAL OF TRANSPLANTATION. 2020. 20 (5):1467-1468 DOI: 10.1111/ajt.15867
IF: 7,338 Q: 1 D: 1
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, MacGowan A, Grier S, Chazan B, Yanovskay A, Ben Ami R, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Maurer. Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020. 55 (2):- DOI: 10.1016/j.ijantimicag.2019.11.004
IF: 4,621 Q: 1
Len O, Los-Arcos I, Aguado JM, Blanes M, Bodro M, Carratala J, Cordero E, Farinas MC, Fernandez-Ruiz M, Fortun J, Gavalda J, Lopez-Medrano F, Lopez-Velez R, Lumbreras C, Mahillo B, Marcos MA, Martin-Davila P, Montejo JM, Moreno A, Munoz P, Norman F, Perez-Saenz, JL (Luis Perez-Saenz, Jose)[ 13 ] ; Pumarola, T (Pumarola, Tomas)[ 1 ] ; Sabe, N (Sabe, Nuria); San-Juan, R (San-Juan, Rafael)[ 1 ] ; Vidal, E (Vidal, Elisa)[ 14 ] ; Dominguez-Gil, B (Dominguez-Gil, Beatriz)[ 9 ]. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus. TRANSPLANTATION REVIEWS. 2020. 34 (2):- DOI: 10.1016/j.trre.2020.100528
IF: 3,262 Q: 2
Cano A, Guzman-Puche J, Garcia-Gutierrez M, Caston JJ, Gracia-Ahufinger I, Perez-Nadales E, Recio M, Natera AM, Marfil-Perez E, Martinez-Martinez L, Torre-Cisneros J. Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2020. 22 ():9-12 DOI: 10.1016/j.jgar.2019.11.007
IF: 2,706 Q: 2
Publications in 2019
Rodriguez-Gomez J, Perez-Nadales E, Gutierrez-Gutierrez B, Machuca I, Martinez-Martinez L, Rivera F, Cano A, Castón JJ, Robles JC, de la Fuente C, Rodriguez-Lopez F, Rodriguez-Baño J, Torre-Cisneros J. Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment. JOURNAL OF INFECTION. 2019. 79. 3. 245-252. DOI: 10.1016/j.jinf.2019.06.014.
IF: 5,099 Q: 1
Machuca I, Gutiérrez-Gutiérrez B, Rivera-Espinar F, Cano A, Gracia-Ahufinger I, Guzman-Puche J, Marfil-Pérez E, Pérez-Nadales E, Castón JJ, Bonomo RA, Carmeli Y, Paterson D, Pascual Á, Martínez-Martínez L, Rodríguez-Baño J, Torre-Cisneros J; REIPI/ESGBIS/INCREMENT group. External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance. Int J Antimicrob Agents. 2019 Oct; 54(4):442-448. doi: 10.1016/j.ijantimicag.2019.07.017. Epub 2019 Aug 1.
IF: 4,615 Q: 1
Ramos-Vivas J, Chapartegui-González I, Fernández-Martínez M, González-Rico C, Fortún J, Escudero R, Marco F, Linares L, Montejo M, Aranzamendi M, Muñoz P, Valerio M, Aguado JM, Resino E, Ahufinger IG, Vega AP, Martínez L, Fariñas MC; ENTHERE Study Group, the Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients. Sci Rep. 2019 Jun 20; 9(1):8928. doi: 10.1038/s41598-019-45060-y.
IF: 4,011 Q: 1
Tacconelli E, Mazzaferri F, Marie de Smet A, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J. ESCMID-EUCIC clinical guidelines on decolonisation of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect. 2019 Jul; 25(7):807-817. doi: 10.1016/j.cmi.2019.01.005. Epub 2019 Jan 29.
IF: 6,425 Q: 1 D: 1
Fernández-Ruiz M, Giménez E, Vinuesa V, Ruiz-Merlo T, Parra P, Amat P, Montejo M, Paez-Vega A, Cantisán S, Torre-Cisneros J, Fortún J, Andrés A, San Juan R, López-Medrano F, Navarro D, Aguado JM; Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Regular monitoring of cytomegalovirus (CMV)-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment. Clin Microbiol Infect. 2019 Mar; 25(3): 381.e1-381.e10. doi: 10.1016/j.cmi.2018.05.010. Epub 2018 May 25.
IF: 6,425 Q: 1 D: 1
Giannella M, Pascale R, Gutiérrez-Gutiérrez B, Cano A, Viale P. The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection. Expert Rev Anti Infect Ther. 2019 Mar 15:1-9. doi: 10.1080/14787210.2019.1595590. PMID: 30876375
IF: 3,141 Q: 2
López-Aladid R, Guiu A, Mosquera MM, López-Medrano F, Cofán F, Linares L, Torre-Cisneros J, Vidal E, Moreno A, Aguado JM, Cordero E, Martin-Gandul C, Carratalá J, Sabé N, Niubó J, Cervera C, Capón A, Cervilla A, Santos M, Bodro M, Muñoz P, Fari-ñas MC, Antón A, Aranzamendi M, Montejo M, Pérez-Romero P, Len O, Marcos MÁ. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next ge-neration sequencing. PLoS One. 2019 Jul 18; 14(7): e0219701. doi: 10.1371/journal.pone.0219701. eCollection 2019. PMID: 31318908
IF: 2,776 Q: 2
Páez-Vega A, Cantisán S, Vaquero JM, Vidal E, Luque-Pineda A, Lobo-Acosta MA, Pérez AB, Alonso-Moralejo R, Iturbe D, Monforte V, Otero-Gonzalez I, Pastor A, Ussetti P, Torre-Cisneros J. Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): An open-label, randomised, non-inferiority clinical trial. BMJ Open. 2019 Aug 15; 9(8): e030648. doi: 10.1136/bmjopen-2019-030648. PMID: 31420397
IF: 2,376 Q: 2
Shepshelovich D, Tau N, Green H, Rozen-Zvi B, Issaschar A, Falcone M, Coussement J, Zusman O, Manuel O, Mor E, Torre-Cisneros J, Yahav D. Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection - a multinational survey. Transpl Infect Dis. 2019 Oct; 21(5): e13134. doi: 10.1111/tid.13134. Epub 2019 Jul 12. PMID: 31242341
IF: 2,112 Q: 3
Sánchez-Fabra D, Dyar OJ, Del Pozo JL, Amiguet JA, Colmenero JD, Fariñas MDC, López-Medrano F, Portilla J, Praena J, Torre-Cisneros J, Rodríguez-Baño J, Pulcini C, Paño-Pardo JR; en representación de ESGAP (ESCMID Study Group for Antimicrobial Stewardship). Perspective of Spanish medical students regarding undergraduate education in infectious diseases, bacterial resistance and antibiotic use. Enferm Infecc Microbiol Clin. 2019 Jan; 37(1):25-30. doi: 10.1016/j.eimc.2017.12.003. Epub 2018 Feb 21. English, Spanish. PMID: 29429753
IF: 1,685 Q: 4
Publications in 2018
Cano A, Gutierrez-Gutierrez B, Machuca I, Gracia-Ahufinger I, Perez-Nadales E, Causse M, Caston JJ, Guzman-Puche J, Torre-Gimenez J, Kindelan L, Martinez-Martinez L, Rodriguez-Bano J, Torre-Cisneros J.Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management. CLINICAL INFECTIOUS DISEASES. 2018; 66(8):1204-1210.
IF:9,117 Q: 1 D: 1
Amat T, Gutierrez-Pizarraya A, Machuca I, Gracia-Ahufinger I, Perez-Nadales E, Torre-Gimenez A, Garnacho-Montero J, Cisneros JM, Torre-Cisneros J. The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii. CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(6):630-634.
IF: 5,394 Q: 1 D: 1
Baddley JW, Cantini F, Goletti D, Gomez-Reino JJ, Mylonakis E, San-Juan R, Fernandez-Ruiz M, Torre-Cisneros J. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-alpha agents). CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24:S10-S20.
IF: 5,394 Q: 1 D: 1
Paez-Vega A, Poyato A, Rodriguez-Benot A, Guirado L, Fortun J, Len O, Abdala E, Farinas MC, Cordero E, de Gracia C, Hernandez D, Gonzalez R, Torre-Cisneros J, Cantisan S.Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG + response. ANTIVIRAL RESEARCH. 2018; 155:97-105.
IF: 4,307 Q: 1
Clemente WT, Mourao PHO, Lopez-Medrano F, Schwartz BS, Garcia-Donoso C, Torre-Cisneros J. Visceral and Cutaneous Leishmaniasis Recommendations for Solid Organ Transplant Recipients and Donors. TRANSPLANTATION. 2018; 102(2):S8-S15.
IF: 3,96 Q: 1 D: 1
Kumar D, Ferreira VH, Blumberg E, Silveira F, Cordero E, Perez-Romero P, Aydillo T, Danziger-Isakov L, Limaye AP, Carratala J, Munoz P, Montejo M, Lopez-Medrano F, Farinas MC, Gavalda J, Moreno A, Levi M, Fortun J, Torre-Cisneros J, Englund JA, Natori Y, Husain S, Reid G, Sharma TS, Humar A. A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients. CLINICAL INFECTIOUS DISEASES. 2018; 67(9):1322-1329.
IF: 9,117 Q: 1 D: 1
Rivero-Juarez A, Aguado R, Lopez-Lopez P, Sanchez-Frias M, Frias M, Briceno J, de la Mata M, Torre-Cisneros J, Rivero A. Prevalence of hepatitis E virus infection in liver donors in Spain. CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(11):1218-1219.
IF: 5,394 Q: 1 D: 1
Rivero-Juarez A, Camacho A, Brieva T, Frias M, Lopez-Lopez P, Risalde MA, Machuca I, Caston JJ, Martinez-Peinado A, Rivero A. Differential Timing of Cholesterol Increase During Successful HCV Therapy: Impact of Type of Drug Combination. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2018; 78(4):437-440.
IF: 4,116 Q: 1
Clemente WT, Pierrotti LC, Abdala E, Morris MI, Azevedo LS, Lopez-Velez R, Cuenca-Estrella M, Torre-Cisneros J, Petersen E, Camargo LFA, Wright AJ, Beeching NJ, Vilela EG, Santoro-Lopes G, Len O, Stucchi RSB, Manuel O, Faria LC, Leblebicioglu H, Huprikar S, Molina I, Mourao PHO, Kotton CN, Aguado JM. Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America. TRANSPLANTATION. 2018; 102(2):193-208.
IF: 3,96 Q: 1 D: 1
Torre-Cisneros J, Natera C, Mesa F, Trikic M, Rodríguez-Baño J. Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study. Eur J Clin Microbiol Infect Dis. 2018 Jan; 37(1): 51-56. doi: 10.1007/s10096-017-3100-y. Epub 2017 Sep 8. PMID: 28887643
IF: 2,537 Q: 2
Serrano-Alonso M, Guillen-Grima F, Martin-Moreno P, Rabago G, Manrique J, Garcia-del-Barrio M, Reina G, Torre-Cisneros J, Fernandez-Alonso M, Herrero JI. Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation. TRANSPLANT INFECTIOUS DISEASE. 2018; 20(3): Núm artículo e12873
IF: 1,869 Q: 3
Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016). Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA/SEIMC/REIPI recommendations. Transplant Rev (Orlando). 2018 Jan; 32(1):36-57. doi: 10.1016/j.trre.2017.07.001. Epub 2017 Jul 26. Review. PMID: 28811074
IF: 2,364 Q: 3
Machuca I, Vidal E, Torre-Cisneros J, Rivero-Roman A. Tuberculosis in immunosuppressed patients. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(6):366-374.
IF: 1,707 Q: 3
Guirao-Arrabal E, Torre-Cisneros J. Tuberculin skin test, Interferon gamma release assays or just chest x-ray to study latent tuberculosis before solid organ transplantation? Transpl Infect Dis. 2018 Aug; 20(4): e12920. doi: 10.1111/tid.12920. Epub 2018 Jun 8. PMID: 29797688
IF: 1,869 Q: 3
Silva JT, Torre-Cisneros J, Aguado JM. Invasive aspergillosis in solid organ transplantation. REVISTA IBEROAMERICANA DE MICOLOGIA. 2018; 35(4):206-209.
IF: 0,989 Q: 4
Aguado R, Páez-Vega A, Agüera ML, Montejo M, Guirado L, Fortún J, Suárez-Benjumea A, Len O, Fariñas MC, de Gracia C, Hernández D, Cobos-Ceballos MJ, Torre-Cisneros J, Cantisán S; Spanish Network for Research in Infectious Diseases and the Spanish Renal Disease Network; Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients. Hum Immunol. 2018 Jun; 79 (6): 499-505. doi: 10.1016/j.humimm.2018.03.009. Epub 2018 Mar 29. PMID: 29605690
IF: 1,994 Q: 4
